Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Acta Neurochir (Wien) ; 163(6): 1757-1761, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-32803371

RESUMEN

BACKGROUND: Dorsal pons cavernoma can be approached through telo-velar approach instead of transvermian approach, with lower risk of neurological deficits since it uses natural clefts to reach the floor of the fourth ventricle. MATERIALS AND METHODS: We present our surgical technique for telo-velar approach to address pathologies of the dorsal pons, assisted by neuronavigation and neuromonitoring. This surgical technique is illustrated by a surgical video of a dorsal pons cavernoma. CONCLUSION: Dorsal pons cavernomas can be reached through telo-velar approach after suboccipital midline craniotomy. The accurate patient positioning, cisternal dissection, and neuromonitoring use are mandatory to avoid neural injuries and identify the safe entry points into the brainstem.


Asunto(s)
Cuarto Ventrículo/cirugía , Hemangioma Cavernoso/cirugía , Tonsila Palatina/cirugía , Puente/cirugía , Craneotomía , Duramadre/cirugía , Humanos , Puente/patología , Complicaciones Posoperatorias/etiología , Factores de Riesgo
2.
Mult Scler ; 19(6): 820-3, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23069873

RESUMEN

Tumor necrosis factor alpha (TNF-α) is a pro-inflammatory and immunoregulatory cytokine involved in the pathogenesis of several autoimmune disorders. Etanercept, a TNF-α antagonist (anti-TNF-α) acting as a soluble TNF-α receptor, has been associated with neurological demyelinating disorders. This paper aims to report an unusual case showing tumefactive central nervous system (CNS) inflammatory demyelination in a patient in the course of TNF -α antagonist therapy, requiring decompressive hemicraniectomy. This report is based on magnetic resonance imaging (MRI) findings and histology. A biopsy confirmed the inflammatory demyelinating nature of the lesions. The clinical presentation is unusual due to the severity of the disease process, requiring decompressive hemicraniotomy with a clinically favorable outcome.


Asunto(s)
Craniectomía Descompresiva/métodos , Enfermedades Desmielinizantes/cirugía , Encefalitis/cirugía , Inmunoglobulina G/efectos adversos , Inmunosupresores/efectos adversos , Espondilitis Anquilosante/tratamiento farmacológico , Adulto , Biopsia , Enfermedades Desmielinizantes/inducido químicamente , Enfermedades Desmielinizantes/diagnóstico , Enfermedades Desmielinizantes/inmunología , Enfermedades Desmielinizantes/fisiopatología , Encefalitis/inducido químicamente , Encefalitis/diagnóstico , Encefalitis/inmunología , Encefalitis/fisiopatología , Etanercept , Humanos , Inmunohistoquímica , Imagen por Resonancia Magnética , Masculino , Receptores del Factor de Necrosis Tumoral , Recuperación de la Función , Espondilitis Anquilosante/diagnóstico , Espondilitis Anquilosante/inmunología , Factores de Tiempo , Resultado del Tratamiento , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA